Dr. Camilo Alejandro Gutierrez, MD

Dr. Gutierrez practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Gutierrez's NPI, 1063623973, was assigned on May 24, 2007. Dr. Gutierrez holds Maryland license D84053.

Dr. Gutierrez's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Gutierrez's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Gutierrez is also affiliated with University of Maryland Medical Center Midtown Campus. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Dr. Gutierrez to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gutierrez practices, 5 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Gutierrez's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dmand AI has Dr. Gutierrez's licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 257 Medicare services from Dr. Gutierrez across 6 procedure codes in 2024, for 182 Medicare patients. Medicare paid $34,505 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 182 Medicare patients who saw Dr. Gutierrez in 2024. The largest group is under 65, with 72 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gutierrez's median patient age at 56, with 47% women.

In 2024, Dr. Gutierrez wrote 1,108 Medicare Part D claims for 98 patients. 84% of them were for generic drugs. CMS names the drug for 1,044 of them, across 22 drugs with 11 or more claims each, at $304,679 in total drug cost. In 2023, CMS named 880 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gutierrez for performance year 2024, reported as part of a group. Dr. Gutierrez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gutierrez as offering telehealth.

Dmand AI links 4 papers to Dr. Gutierrez, published from 2020 to 2024. The most frequent topics are Neurology. Dr. Gutierrez has published most often in Neurology. Dr. Gutierrez's most frequent co-authors are Elsie Achieng, MD, Neeraj Badjatia, MD and Madeline A. Chadehumbe, MD.

CMS Open Payments shows 7 general payments to Dr. Gutierrez from 4 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 64% of the total. Neuropace, Inc. paid the most, $642.